These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 7886694)
41. Individual expression patterns of myotoxin isoforms in the venom of the snake Bothrops asper. Lomonte B; Carmona E Comp Biochem Physiol B; 1992 Jun; 102(2):325-9. PubMed ID: 1617940 [TBL] [Abstract][Full Text] [Related]
42. Identification of the myotoxic site of the Lys49 phospholipase A(2) from Agkistrodon piscivorus piscivorus snake venom: synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities. Núñez CE; Angulo Y; Lomonte B Toxicon; 2001 Oct; 39(10):1587-94. PubMed ID: 11478967 [TBL] [Abstract][Full Text] [Related]
43. Biochemical characterization and pharmacological properties of a phospholipase A2 myotoxin inhibitor from the plasma of the snake Bothrops asper. Lizano S; Lomonte B; Fox JW; Gutiérrez JM Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):853-9. PubMed ID: 9307037 [TBL] [Abstract][Full Text] [Related]
44. Bactericidal and antiendotoxic properties of short cationic peptides derived from a snake venom Lys49 phospholipase A2. Santamaría C; Larios S; Quirós S; Pizarro-Cerda J; Gorvel JP; Lomonte B; Moreno E Antimicrob Agents Chemother; 2005 Apr; 49(4):1340-5. PubMed ID: 15793109 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of the myotoxic activity of Bothrops asper myotoxin II in mice by immunization with its synthetic 13-mer peptide 115-129. Calderón L; Lomonte B Toxicon; 1999 Apr; 37(4):683-7. PubMed ID: 10082167 [TBL] [Abstract][Full Text] [Related]
46. Localization of Myotoxin I and Myotoxin II from the venom of Bothrops asper in a murine model. Vargas-Valerio S; Robleto J; Chaves-Araya S; Monturiol-Gross L; Lomonte B; Tonello F; Fernández J Toxicon; 2021 Jul; 197():48-54. PubMed ID: 33862027 [TBL] [Abstract][Full Text] [Related]
47. Host response to Bothrops asper snake venom. Analysis of edema formation, inflammatory cells, and cytokine release in a mouse model. Lomonte B; Tarkowski A; Hanson LA Inflammation; 1993 Apr; 17(2):93-105. PubMed ID: 8491517 [TBL] [Abstract][Full Text] [Related]
48. Effects of a myotoxic phospholipase A2 isolated from Bothrops asper venom on skeletal muscle sarcoplasmic reticulum. Gutiérrez JM; Rojas G; Lomonte B; Gené JA; Cerdas L Toxicon; 1987; 25(11):1244-8. PubMed ID: 2963409 [TBL] [Abstract][Full Text] [Related]
49. LYS49 phospholipase A2 myotoxins lyse cell cultures by two distinct mechanisms. Fletcher JE; Jiang MS Toxicon; 1998 Nov; 36(11):1549-55. PubMed ID: 9792171 [TBL] [Abstract][Full Text] [Related]
51. Equine antibodies to Bothrops asper myotoxin II: isolation from polyvalent antivenom and neutralizing ability. Lomonte B; Gutiérrez JM; Carmona E; Rovira ME Toxicon; 1990; 28(4):379-84. PubMed ID: 2349580 [TBL] [Abstract][Full Text] [Related]
52. Crystallization and preliminary diffraction data of two myotoxins isolated from the venoms of Bothrops asper (Terciopelo) and Bothrops nummifer (jumping viper). Arni RK; Gutiérrez JM Toxicon; 1993 Aug; 31(8):1061-4. PubMed ID: 8212044 [TBL] [Abstract][Full Text] [Related]
53. Two phospholipase A2 inhibitors from the plasma of Cerrophidion (Bothrops) godmani which selectively inhibit two different group-II phospholipase A2 myotoxins from its own venom: isolation, molecular cloning and biological properties. Lizano S; Angulo Y; Lomonte B; Fox JW; Lambeau G; Lazdunski M; Gutiérrez JM Biochem J; 2000 Mar; 346 Pt 3(Pt 3):631-9. PubMed ID: 10698689 [TBL] [Abstract][Full Text] [Related]
54. Cloning and cDNA sequence analysis of Lys(49) and Asp(49) basic phospholipase A(2) myotoxin isoforms from Bothrops asper. Lizano S; Lambeau G; Lazdunski M Int J Biochem Cell Biol; 2001 Feb; 33(2):127-32. PubMed ID: 11240369 [TBL] [Abstract][Full Text] [Related]
55. Isolation and partial characterization of a myotoxin from the venom of the snake Bothrops nummifer. Gutiérrez JM; Lomonte B; Cerdas L Toxicon; 1986; 24(9):885-94. PubMed ID: 3810663 [TBL] [Abstract][Full Text] [Related]
56. Immunoenzymatic quantitation of antibodies to Bothrops asper myotoxins after polyvalent antivenom administration in mice. Rovira ME; Carmona E; Lomonte B Braz J Med Biol Res; 1992; 25(1):23-33. PubMed ID: 1304940 [TBL] [Abstract][Full Text] [Related]
57. Solving the microheterogeneity of Bothrops asper myotoxin-II by high-resolution mass spectrometry: Insights into C-terminal region variability in Lys49-phospholipase A Lomonte B; Fernández J Toxicon; 2022 Apr; 210():123-131. PubMed ID: 35248586 [TBL] [Abstract][Full Text] [Related]
58. Isolation of an acidic phospholipase A2 from the venom of the snake Bothrops asper of Costa Rica: biochemical and toxicological characterization. Fernández J; Gutiérrez JM; Angulo Y; Sanz L; Juárez P; Calvete JJ; Lomonte B Biochimie; 2010 Mar; 92(3):273-83. PubMed ID: 20026168 [TBL] [Abstract][Full Text] [Related]
59. Identification of linear B-cell epitopes on myotoxin II, a Lys49 phospholipase A₂ homologue from Bothrops asper snake venom. Lomonte B Toxicon; 2012 Oct; 60(5):782-90. PubMed ID: 22677805 [TBL] [Abstract][Full Text] [Related]
60. Chemical modification of histidine and lysine residues of myotoxic phospholipases A2 isolated from Bothrops asper and Bothrops godmani snake venoms: effects on enzymatic and pharmacological properties. Díaz-Oreiro C; Gutiérrez JM Toxicon; 1997 Feb; 35(2):241-52. PubMed ID: 9080581 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]